Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More

SYS6017 is an investigational lipid nanoparticle (LNP)-coated mRNA vaccine encoding the glycoprotein E (gE) of VZV, and indicated for active immunization for the prevention of zoster caused by the reactivation of latent VZV.

saline solution